Applications of P-Nitrophenyl 2-(Furfurylsulfinyl)Acetate in Industrial Manufacturing

As a direct manufacturer, we support precise industrial applications for P-Nitrophenyl 2-(Furfurylsulfinyl)Acetate across specialized sectors. This intermediate finds use exclusively in downstream manufacturing processes where stringent regulatory, formulation, and functional demands govern adoption. The following scenarios outline real deployment across organic synthesis, pharmaceutical development, crop protection R&D, and fine chemical building block production, each substantiated by practical manufacturing data, recognized regulatory standards, and explicit process guidance.

1. Active Pharmaceutical Ingredient (API) Intermediate Synthesis

Pharmaceutical manufacturers employ this compound as a selective acylating agent or cleavage substrate in multi-step syntheses for heterocyclic drug candidates. Its unique reactivity streamlines the introduction of furfuryl and nitrophenyl functional groups without producing excessive byproducts, reducing downstream purification. This efficiency supports batch-to-batch consistency in regulated API production, particularly where sensitive oxidative and nucleophilic reactions form a structural motif integral to active molecules for antifungal or antiviral indications.

Industry compliance standards

• ICH Q7 GMP for Active Pharmaceutical Ingredients
• USP–NF and European Pharmacopoeia (Ph. Eur.) for residual solvents and intermediates
• FDA 21 CFR Part 210/211 for process control
• EDQM TSE/BSE-free certification if required by pathway

Typical usage ratio

• 0.5–2.5 molar equivalents, adjusted according to the target coupling yield and reactivity profile in the optimized reaction step. Usage scales with intermediate stability and downstream solvent compatibility.

Downstream process integration

• Added in the condensation or acylation stage following preliminary salt-base neutralization; typically introduced under inert gas to maintain selectivity; followed by aqueous quenching and organic extraction prior to purification.

Final product types

• Small molecule APIs for anti-infectives
• Chiral drug intermediates leading to finished dosage forms
• Specialty heterocyclic compounds for investigational new drugs (INDs)

2. Agrochemical Research Intermediate

R&D laboratories within the agrochemical sector use P-Nitrophenyl 2-(Furfurylsulfinyl)Acetate as a precise carrier for developing potential herbicidal and fungicidal agents requiring furyl-based motifs. The material acts as a building block in controlled substitution or hydrolysis reactions directed at assembling sulfur-containing bioactive scaffolds. Enhanced selectivity in these transformations allows downstream teams to fine-tune structure–activity relationships in candidate evaluation studies.

Industry compliance standards

• OECD Principles of Good Laboratory Practice (GLP)
• FAO/WHO specifications for technical grade raw materials
• ISO 17025 traceability for analytical reference standards
• REACH (EC No 1907/2006) substance registration for new actives

Typical usage ratio

• 2–10% w/w in laboratory formulation screening; levels adjusted per reaction scale and functional group performance for each synthetic route. Screening concentrations reflect solubility and reactivity requirements.

Downstream process integration

• Charged during synthesis of novel aryl-substituted thiols prior to catalytic hydrogenation; removed after directed chemical transformation to yield the active R&D compound for bioassay.

Final product types

• Novel fungicide screening leads
• Experimental pre-emergent and post-emergent herbicides
• Pilot-scale agrochemical active ingredients for regulatory submission

3. Chromogenic Substrate Manufacturing for Biochemical Assays

Specialist diagnostics manufacturers select this compound when formulating chromogenic enzyme substrates for spectrophotometric assay development, particularly in academic or clinical research where the detection of specific hydrolases or oxidoreductases is required. The high purity and reactivity ensure sharp color development upon enzymatic cleavage, supporting quantifiable endpoint measurement with minimized background interference.

Industry compliance standards

• ISO 13485:2016 for in vitro diagnostic (IVD) device components
• CLSI guidelines for analytical specificity and sensitivity
• IVD Regulation (EU 2017/746) materials traceability for CE-marked assays
• Biological evaluation as per ISO 10993 for materials in contact with specimen

Typical usage ratio

• 0.01–1.0 mg/mL, based on enzyme turnover rate and target signal window. Optimization performed by enzymology teams to attain clear colorimetric differentiation per application.

Downstream process integration

• Dry-blended into assay buffer matrices during substrate preparation; integrated in automated filling lines prior to lyophilization or as concentrate for liquid reagent sets.

Final product types

• Enzyme-based diagnostic test kits
• Clinical analyzer reagents for high-throughput screening
• Biochemical research substrate panels for academic laboratories

4. Fine Chemical Intermediate for Heterocycle Construction

Producers of specialty fine chemicals rely on this acetate as an activated leaving group in multi-step routes involving furanyl or nitroaromatic substitution. Its defined functional profile streamlines synthesis of complex heterocycles used in OLED materials, high-value ligands, and other advanced materials, where process chemists require consistent coupling efficiency and reliable product isolation at kilogram scale.

Industry compliance standards

• ISO 9001:2015 Quality Management System for production traceability
• Responsible Care® for chemical handling and safety
• National Fire Protection Association (NFPA) chemical storage standards

Typical usage ratio

• 5–15% mol/mol based on structure–reactivity mapping for each synthetic step; process optimization dictates minor adjustment dependent on substituent effects and downstream purification constraints.

Downstream process integration

• Fed at the nucleophilic substitution or ring closure stage, under anhydrous conditions, with staged heating or catalyst addition as specified by reaction protocol; excess removed during aqueous work-up and column chromatography.

Final product types

• Functionalized heterocycle intermediates
• Material science building blocks (OLED, organic electronics)
• Chemical ligands for catalysis